Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Clinical and Brain Activity Assessment Before and After Physiotherapy in People With Chronic Non-specific Neck Pain

22 septembre 2026 mis à jour par: Ander Cervantes Benítez

Predictors of Response After Physiotherapy Treatment in People With Chronic Non-specific Neck Pain

The goal of this clinical trial is to investigate whether electroencephalographic features are associated with the multidimensional clinical characteristics of adults with chronic non-specific neck pain and whether clinical and brain function measures change following physiotherapy. Participants with chronic non-specific neck pain will receive six weekly treatment sessions consisting of a manual physiotherapy and neck-specific exercise programme, including a home exercise programme. Clinical, psychophysical, and 64-channel electroencephalographic assessments will be performed at baseline and approximately one week after completion of the intervention. Clinical outcomes will also be reassessed 12 weeks after the last treatment session. Electroencephalographic recordings will be obtained while participants are seated comfortably and instructed to remain relaxed. EEG-derived measures will be examined in relation to pain intensity, neck-related disability, psychological and cognitive-affective factors, sleep quality, and psychophysical pain responses. Healthy participants without chronic neck pain will undergo a comparable baseline assessment to provide reference data for the interpretation of brain function in the clinical group.

Aperçu de l'étude

Description détaillée

This non-randomized interventional study aims to investigate clinical and electroencephalographic characteristics in individuals with chronic non-specific neck pain and to examine changes following a physiotherapy intervention. A healthy control group will also be assessed to provide reference data for comparison with participants with chronic non-specific neck pain.

Participants with chronic non-specific neck pain will undergo a baseline assessment including clinical questionnaires, pain mapping, quantitative sensory testing, and 64-channel electroencephalographic recordings.

Following the baseline assessment, participants with chronic non-specific neck pain will receive six weekly physiotherapy sessions. The intervention will include passive mobilizations of the cervical and thoracic spine, soft tissue mobilizations, and a neck-specific home exercise programme involving neck flexor and extensor training.

The clinical, psychophysical, and electroencephalographic assessments will be repeated approximately one week after completion of the intervention. Perceived recovery, pain intensity, and neck-related disability will also be evaluated approximately 12 weeks after the final treatment session.

The study will examine baseline differences between participants with chronic non-specific neck pain and healthy controls and changes in clinical and electroencephalographic outcomes following physiotherapy.

Type d'étude

Interventionnel

Inscription (Estimé)

100

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Guipuzcoa
      • San Sebastián, Guipuzcoa, Espagne, 20012
        • Recrutement
        • Ander Cervantes Benítez
        • Contact:
        • Sous-enquêteur:
          • Ander Cervantes Benítez

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Chronic non-specific neck pain (>3 months duration)
  • Willing and able to sign informed consent for study participation

Exclusion Criteria:

  • Concomitant neurological or psychiatric disease apart from depression (especially severe mental disorder or psychopathology)
  • Regular (daily) intake of benzodiazepines
  • Signs of severe disease, cervical myelopathy, tumour, rheumatic diseases or a neurological pathology of central origin
  • Neck pain of traumatic origin or as a result of whiplash
  • Previous surgical intervention of the cervical spine

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: N / A
  • Modèle interventionnel: Affectation à un seul groupe
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Physiotherapy group

Participants with chronic non-specific neck pain will receive a 6-week physiotherapy intervention consisting of six individual treatment sessions, including manual therapy directed at the cervical and thoracic regions, together with a home exercise program. Clinical and brain activity assessments will be performed before the intervention and approximately one week after completion of the intervention.

The physiotherapy intervention will consist of six weekly sessions combining manual physiotherapy and a neck-specific exercise programme. Manual physiotherapy will include passive mobilisations of the cervical and thoracic spine and soft tissue techniques. The exercise programme will include daily home exercises targeting cervical mobility and neuromuscular control, including neck flexor and neck extensor training. The intervention is based on the protocol described by Villanueva-Ruiz et al. (2025).

Autres noms:
  • Manual therapy and neck exercise

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Global Rating of Change (GROC) scale
Délai: Post-intervention (approximately 1 week after treatment completion and 12 weeks after the last treatment session)

It is a single-item patient-reported outcome that aims to quantify a patient's perceived improvement or deterioration over time. The questionnaire is scored with 7 positive items to assess the patient's subjective improvement progressively. It also presents 7 negative items to assess whether the patient has worsened. The 0 is defined as no improvement or worsening.

Post-intervention (approximately 1 week after treatment completion and 12 weeks after the last treatment session)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Numeric Pain Rating Scale (NPRS)
Délai: Baseline and post-intervention (approximately 1 week after treatment completion and 12 weeks after the last treatment session)

11-point tool used to measure pain intensity from 0 (no pain) to 10 (worst pain imaginable)

Baseline and post-intervention (approximately 1 week after treatment completion and 12 weeks after the last treatment session)
Neck Disability Index (NDI)
Délai: Baseline and post-intervention (approximately 1 week after treatment completion and 12 weeks after the last treatment session)

The Neck Disability Index consists of 10 items assessing disability related to neck pain. Each item is scored from 0 to 5, giving a total score from 0 to 50. Higher scores indicate greater neck-related disability. The score may also be expressed as a percentage from 0% to 100%.

Baseline and post-intervention (approximately 1 week after treatment completion and 12 weeks after the last treatment session)

Autres mesures de résultats

Mesure des résultats
Description de la mesure
Délai
Electroencephalographic spectral characteristics
Délai: Baseline and post-intervention (approximately 1 week after treatment completion)

Spectral characteristics will be derived from 64-channel electroencephalography recorded while participants are seated comfortably with their eyes closed in a quiet environment and instructed to remain relaxed and minimize movement. Mean peak alpha frequency will be reported in hertz (Hz) at baseline and post-intervention.

Baseline and post-intervention (approximately 1 week after treatment completion)
Pain Catastrophizing Scale (PCS)
Délai: Baseline and post-intervention (approximately 1 week after treatment completion)

The Pain Catastrophizing Scale consists of 13 items scored from 0 to 4. The total score ranges from 0 to 52, with higher scores indicating greater pain catastrophizing.

Baseline and post-intervention (approximately 1 week after treatment completion)
Hospital Anxiety and Depression Scale (HADS)
Délai: Baseline and post-intervention (approximately 1 week after treatment completion)

Anxiety and depressive symptoms will be assessed using the 14-item Hospital Anxiety and Depression Scale. The anxiety and depression subscale scores will be summed to obtain a total score ranging from 0 to 42, with higher scores indicating greater psychological distress.

Baseline and post-intervention (approximately 1 week after treatment completion)
Central Sensitization Inventory (CSI)
Délai: Baseline and post-intervention (approximately 1 week after treatment completion)

Symptoms associated with central sensitization will be assessed using Part A of the 25-item Central Sensitization Inventory. The total score ranges from 0 to 100, with higher scores indicating greater symptom severity.

Baseline and post-intervention (approximately 1 week after treatment completion)
Tampa Scale for Kinesiophobia-11
Délai: Baseline and post-intervention (approximately 1 week after treatment completion)

Fear of movement will be assessed using the 11-item Tampa Scale for Kinesiophobia. The total score ranges from 11 to 44, with higher scores indicating greater kinesiophobia.

Baseline and post-intervention (approximately 1 week after treatment completion)
Sleep quality
Délai: Baseline and post-intervention (approximately 1 week after treatment completion)

Sleep quality will be assessed using a single 0-to-10 numerical rating scale, where 0 indicates the worst possible sleep quality and 10 indicates the best possible sleep quality.

Baseline and post-intervention (approximately 1 week after treatment completion)
Pain mapping
Délai: Baseline and post-intervention (approximately 1 week after treatment completion)

Participants will indicate the location and extent of their pain using a digital body chart. Total pain extent will be calculated as the percentage of the body chart area marked as painful.

Baseline and post-intervention (approximately 1 week after treatment completion)
Pressure pain threshold
Délai: Baseline and post-intervention (approximately 1 week after treatment completion)

Pressure pain threshold will be assessed using a pressure algometer with a 1-cm² contact surface. Participants will be instructed to press a button when the sensation first changes from pressure to pain. Measurements will be performed at the most painful cervical location and at the contralateral hand. Three measurements will be obtained at each anatomical location, and the mean of the three measurements will be used for analysis. Values from the cervical location and the hand will be reported separately. Results will be reported in kilopascals.

Baseline and post-intervention (approximately 1 week after treatment completion)
Cold pain threshold
Délai: Baseline and post-intervention (approximately 1 week after treatment completion)

Cold pain threshold will be assessed as part of a quantitative sensory testing protocol using the MSA Thermotest (Somedic) with a 9-cm² contact thermode. The baseline temperature will be set at 32°C, and the minimum safety limit will be 5°C. Temperature will decrease at a rate of 1°C/s. Participants will press a button when the cold sensation first becomes painful, immediately stopping the stimulus. Three valid consecutive measurements will be obtained, and their mean temperature will be used for analysis. Results will be reported in degrees Celsius.

Baseline and post-intervention (approximately 1 week after treatment completion)
Heat pain threshold
Délai: Baseline and post-intervention (approximately 1 week after treatment completion)

Heat pain threshold will be assessed as part of a quantitative sensory testing protocol using the MSA Thermotest (Somedic) with a 9-cm² contact thermode. The baseline temperature will be set at 32°C, and the maximum safety limit will be 50°C. Temperature will increase at a rate of 1°C/s. Participants will press a button when the heat sensation first becomes painful, immediately stopping the stimulus. Three valid consecutive measurements will be obtained, and their mean temperature will be used for analysis. Results will be reported in degrees Celsius.

Baseline and post-intervention (approximately 1 week after treatment completion)
Temporal summation of pain
Délai: Baseline and post-intervention (approximately 1 week after treatment completion)

Mechanical temporal summation of pain will be assessed using calibrated pinprick stimulators (MRC Systems). Participants will rate the perceived pain intensity of a single 256-mN pinprick stimulus and the overall pain intensity elicited by a series of 10 pinprick stimuli of the same force applied at a rate of 1 stimulus per second. Pain intensity will be rated using a numerical rating scale ranging from 0, no pain, to 10, worst imaginable pain. The temporal summation ratio will be calculated by dividing the pain rating for the series of 10 stimuli by the pain rating for the single stimulus. When the pain rating for the single stimulus is 0, a value of 1 will be used as the denominator to avoid division by zero. Higher ratios indicate greater temporal summation of pain.

Baseline and post-intervention (approximately 1 week after treatment completion)
Conditioned pain modulation
Délai: Baseline and post-intervention (approximately 1 week after treatment completion)

Conditioned pain modulation will be assessed using the cold pressor test as the conditioning stimulus and pressure pain threshold as the test stimulus. Participants will immerse the foot contralateral to the most painful cervical location in an insulated container filled with cold water, initially set at 10°C, for up to 2 minutes. The water temperature may be adjusted to achieve a pain intensity of approximately 5 out of 10. Immediately after removal of the conditioning stimulus, pressure pain threshold will be measured three times at the cervical location, with 15 seconds between measurements, and the mean of the three measurements will be used for analysis. The conditioned pain modulation response will be calculated as the absolute change in pressure pain threshold between the pre-conditioning and post-conditioning measurements and reported in kilopascals (kPa). Higher positive values indicate greater endogenous pain inhibition.

Baseline and post-intervention (approximately 1 week after treatment completion)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

21 mars 2024

Achèvement primaire (Estimé)

1 mars 2027

Achèvement de l'étude (Estimé)

1 décembre 2027

Dates d'inscription aux études

Première soumission

31 juillet 2026

Première soumission répondant aux critères de contrôle qualité

5 août 2026

Première publication (Réel)

10 août 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

25 septembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

22 septembre 2026

Dernière vérification

1 juillet 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • FST_CCNE

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

INDÉCIS

Description du régime IPD

A final decision regarding individual participant data sharing has not yet been made. Pseudonymized individual participant data underlying the results reported in the main publications may be made available through an Open Science Framework repository upon publication. Data sharing will depend on participant consent, approval by the study investigators and relevant ethics bodies, and compliance with applicable data protection and institutional requirements.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner